Onc Now: Cancer Vaccines and the Future of Immunotherapy

In this episode of Onc Now, Mary Disis, Director of the University of Washington's Medicine Cancer Vaccine Institute, Seattle, USA, explores the science and future of cancer vaccines. She discusses how vaccines fit into today's immunotherapy landscape, the evolution of human epidermal growth factor receptor 2 (HER2)-targeted therapies, progress in breast cancer vaccines, the promise of cancer prevention, and the key priorities for survivorship and future oncology care.  Timestamps:   00:00 – Introduction   01:28 – Cancer Vaccines Explained   03:57 – Journey Into Cancer Immunology   06:38 – Cancer Vaccines in Immunotherapy   10:02 – Leading the Cancer Vaccine Institute   13:26 – Progress in Breast Cancer Vaccines   18:39 – HER2 Research and Treatment Evolution   21:30 – Future of Preventive Cancer Vaccines   26:39 – Priorities for Cancer Survivorship   30:30 – Three Wishes for Oncology's Future